Clinical Determinants of Successful Omalizumab Therapy in Severe Allergic Asthma Patients: 4-Year-Long, Real-Life Observation

INTRODUCTION: Omalizumab is a high-cost therapy recommended for the treatment of severe allergic asthma. OBJECTIVE: To find clinical parameters that are related to the sustained response to omalizumab. PATIENTS AND METHODS: This retrospective, real-life, 4-year follow-up was provided in Poland betwe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Asthma Allergy
Asıl Yazarlar: Kucharczyk, Aleksandra, Więsik-Szewczyk, Ewa, Poznańska, Anna, Jahnz-Różyk, Karina
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove 2020
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7754267/
https://ncbi.nlm.nih.gov/pubmed/33363390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S282203
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller